Award
Delivery Order #SPE2DP26F6554
Delivery Order for Dexamethasone Supply under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$141.89
Ceiling
$141.89
Awarded
June 15, 2026
Period of Performance
Jun 15, 2026 – Jun 30, 2026
Identifier
SPE2DP26F6554
NAICS
424210
This award is a delivery order contract issued under an existing indefinite delivery vehicle (IDV) acquisition, specifically the definitive pharmaceutical supply contract held by DMS Pharmaceutical Group Inc. DMS Pharmaceutical Group, a known pharmaceutical distributor, specializes in providing critical medical drug inventories to the federal government, supporting public health programs. The current contract focuses on the procurement of a specific corticosteroid, dexamethasone sodium, a vital medication used for its anti-inflammatory and immunosuppressant properties in various medical treatments. This delivery order is significant as it ensures the federal health agencies maintain access to this essential drug, underpinning ongoing efforts in healthcare provision. The scope includes prompt delivery and supply of dexamethasone sodium to the designated place of performance in Park Ridge, Illinois, over a short, defined period. This award was made as a follow-on order to the established long-term definitive pharmaceutical contract, suggesting a streamlined procurement process within a competitive framework. The timeline for this supply order is a concise two-week period, reflecting urgent or routine resupply needs within the broader multi-year contract. No key subcontractors or original solicitation details are indicated for this specific order.
Description
8512185460!DEXAMETHASONE SODIU